Emami Limited · NSE:EMAMILTD

Emami — Q4 FY2024 Earnings Presentation

28 slides from Emami's earnings presentation, May 30, 2024

  1. Slide 1: Press Release and Investor Presentation cover letter to exchanges

    Date: 29th May, 2024 The Manager - Listing The Manager - Listing The National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, Plot No. C/1, G. Block Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Scrip Code: EMAMILTD Scrip Code: 531

  2. Slide 2: Emami posts healthy volume led growth in Q4FY24

    EMAMI POSTS HEALTHY VOLUME LED GROWTH IN Q4FY24. Q4FY24 HIGHLIGHTS  Consolidated Net Sales at ₹ 881 crore grew by 8% o Revenue from Operations at ₹ 891 crore grew by 7% o Domestic Business grew by 8% (Volume growth of 6.4%) o International Business grew by 8% (Constant currency growth of 9%)  Gros

  3. Slide 3: FY24 results, sustainability and management commentary

    Overall the Company launched more than 50 products and variants in the Domestic and International market in FY24 with majority being Digital first products. In Q4FY24, Gross margins at 65.8% expanded by 270 basis points. EBIDTA at ₹211 crore grew by 6%, despite strong investments behind brands which

  4. Slide 4: About Emami Ltd

    About Emami Ltd Emami: (NSE: EMAMILTD, BSE: 531162) Emami Ltd, founded in 1974, is one of India’s leading FMCG Companies engaged in manufacturing & marketing of personal care & healthcare products. With over 450 diverse products, Emami’s portfolio includes trusted power brands like Navratna, BoroPlu

  5. Slide 5: Q4 & FY24 Performance Update

    Q4 & FY24 Performance Update 29th May 2024

  6. Slide 6: Q4FY24 Performance Snapshot

    Q4FY24 Performance Snapshot Margins Domestic Domestic International International Gross Margins Consolidated Business (volume) Business (value) Business Business (Constant Currency) (INR) Net Sales +270 bps +6% +8% +9% +8% +8% A&P Spends +470 bps EBIDTA Margins Consol. Material A&P EBIDTA PAT Revenu

  7. Slide 7: FY24 Performance Snapshot

    FY24 Performance Snapshot Margins Domestic Domestic International International Gross Margins Consolidated Business (volume) Business (value) Business Business Net Sales +290 bps (Constant Currency) (INR) +2% +4% +12% +9% +5% A&P Spends +170 bps EBIDTA Margins Consol. Material A&P EBIDTA PAT Revenue

  8. Slide 8: Brand wise performance

    Brand wise performance Navratna & Dermicool Range Pain Management Range Q4 Q4 growth growth +1% +9% FY FY growth growth +1% +6% ▹ Navratna Cool Oil volume Market share improved by 40 bps to ▹ Penetration levels for Zandu Balms (22.5%) and Mentho Plus 63.6% in Q4FY24. Maintained leadership at 62.8% i

  9. Slide 9: Brand wise performance

    Brand wise performance Healthcare Range BoroPlus Range Q4 Q4 growth growth +10% +33% FY FY growth growth +5% -3% ▹ Strong growth in Zandu Ayurvedic Cough Syrup, Mugdha ▹ Strong growth led by BoroPlus Creams, Body Lotions and Prickly Rasa, Zandu Health Juices and Zanducare Heat Powder in Q4FY24 ▹ Lau

  10. Slide 10: Brand wise performance

    Brand wise performance Kesh King Range Q4 Male Grooming Range Q4 growth growth -9% -2% FY FY growth growth -6% -3% ▹ Kesh King Oil Volume Market Share increased by 20 bps to ▹ Fair and Handsome Cream volume market share at 68.8% 29.3% in MAT Mar’24. increased by 130 bps in Q4. Maintained leadership

  11. Slide 11: Strategic Subsidiaries

    Strategic Subsidiaries 5x growth in Revenues… 5x x FY20 FY21 FY22 FY23 FY24 …with improving profitability Robust sales growth of 86% in Q4FY24 and 59% in FY24 FY20 FY21 FY22 FY23 FY24 7

  12. Slide 12: NPD's: Domestic Business

    NPD’s: Domestic Business Fair and Handsome New launches on Zanducare D2C Portal Nature F1rst Range (Radiance Cream and Facewash) Zandu Digestive Zandu DiaBTS Care Zandu Hair Vitalizer Zandu Seniorz Care Juice Juice Juice Prostate Care Juice 35+ New products and variants launched in FY24 8

  13. Slide 13: Exclusive Business Outlets for Zandu Healthcare

    Exclusive Business Outlets for Zandu Healthcare Piloted 3 EBO’s in Delhi NCR to help in brand resonance and amplification 9

  14. Slide 14: Deepening Consumer Connect: ATL Campaigns

    Deepening Consumer Connect: ATL Campaigns New TVC’s Print Campaigns Navratna – “Thandak Ka Badshah” Zandu Ortho Vedic Oil campaign- “Khole campaign with Kapil Sharma & team Jodon Ke Dard Ka Taala” with Bobby Deol Social Media Posts Dynamic Creative Optimization for Navratna Digital campaign for Zand

  15. Slide 15: Deepening Consumer Connect: BTL Initiatives

    Deepening Consumer Connect : BTL Initiatives Dealer Boards Boat Branding BTL Activations at Reliance Outlets Salon Contact Participation in religious gatherings Sampling at National IAP Wall Paintings Conference MT Visibility Retail visibility & POSM Sampling Van Activations Auto Branding 11

  16. Slide 16: International Business

    International Business Q4 Constant Q4 Reported FY Constant FY 24 FY Reported Currency Growth Growth Currency Growth Contribution to Growth total Net sales +9% +8% +12% +9% 17.5% FY24 Cluster wise Contribution SAARC & SEA portfolio MENA Portfolio CIS Portfolio Others CIS 7% 10% SAARC & SEA 39% MENA 4

  17. Slide 17: NPD's: International Business

    NPD’s: International Business 7 Oils in One Damage Repair Conditioner Range Creme 21 Skin Oils Creme 21 Baby Range Miracle almond, Elixir Blackseed, Purifying Aloe 100% natural vitamin rich oils Oil, Lotion, Bath, Shampoo & Creams Vera and Mystic Olive variants 15 New products and variants launched

  18. Slide 18: Q4FY24 Profitability

    Q4FY24 Profitability Q4FY24 Q4FY24 Q4FY24 Q4FY24 Q4FY24 Revenues Gross Profit A&P Spends EBIDTA PAT ₹ 891 cr ₹ 586 cr ₹ 180 cr ₹ 211 cr ₹ 149 cr Revenue Gross Profit A&P Spends EBIDTA PAT Growth Growth Growth Growth Growth +7% +11% +39% +6% +3% 14

  19. Slide 19: Q4FY24 Financial Analysis

    Q4FY24 Financial Analysis Cost of Goods Sold Staff Costs A&P Costs (as a % of Revenues) (as a % of Revenues) (as a % of Revenues) -270 bps -80 bps +470 bps 36.9% 34.2% 11.0% 10.2% 20.2% 15.5% Q4FY23 Q4FY24 Q4FY23 Q4FY24 Q4FY23 Q4FY24 Declined by 1% over PY Declined by 2% over PY Grew by 39% over PY

  20. Slide 20: FY24 Profitability

    FY24 Profitability FY24 FY24 FY24 FY24 FY24 Revenues Gross Profit A&P Spends EBIDTA PAT ₹ 3,578 cr ₹ 2,418 cr ₹ 652 cr ₹ 950 cr ₹ 724 cr Revenue Gross Profit A&P Spends EBIDTA PAT Growth Growth Growth Growth Growth +5% +10% +16% +10% +13% 16

  21. Slide 21: FY24 Financial Analysis

    FY24 Financial Analysis Cost of Goods Sold Staff Costs A&P Costs (as a % of Revenues) (as a % of Revenues) (as a % of Revenues) -290 bps +30 bps +170 bps 35.3% 16.5% 18.2% 32.4% 10.8% 11.1% FY23 FY24 FY23 FY24 FY23 FY24 Declined by 3% over PY Grew by 8% over PY Grew by 16% over PY Admin & Other Exp

  22. Slide 22: Q4FY24 Consolidated Financials

    Q4FY24 Consolidated Financials ₹ in crore Growth over Particulars Q4FY24 % Q4FY23 % PY Net Sales 880.9 98.8% 816.6 97.7% 7.9% Other Operating Income 10.4 1.2% 19.4 2.3% -46.4% Revenue from Operations 891.2 100.0% 836.0 100.0% 6.6% Materials Cost 304.9 34.2% 308.2 36.9% -1.0% A&P 180.2 20.2% 129.7 15

  23. Slide 23: FY24 Consolidated Financials

    FY24 Consolidated Financials ₹ in crore Growth over Particulars FY24 % FY23 % PY Net Sales 3,530.3 98.7% 3,362.0 98.7% 5.0% Other Operating Income 47.8 1.3% 43.7 1.3% 9.4% Revenue from Operations 3,578.1 100.0% 3,405.7 100.0% 5.1% Materials Cost 1,160.5 32.4% 1,201.4 35.3% -3.4% A&P 652.2 18.2% 560.

  24. Slide 24: Balance Sheet

    Balance Sheet ₹ in crore As at As at As at 31.12.2024 As at 31.12.2024 Sl. Equity & Liabilities 31.03.2023 Sl. Assets 31.03.2023 Audited Audited Audited Audited EQUITY Non -Current Assets (a) Equity Share capital 43.7 44.1 (a) Property, Plant and Equipment 581.1 630.1 (b) Other Equity 2,402.9 2,258.

  25. Slide 25: Rewarding Shareholders

    Rewarding Shareholders’ Dividend Buyback of Shares 1st Interim 2nd Interim Total Dividend Dividend Dividend Dividend per share ₹4.0 ₹4.0 ₹8.0 Outlay ₹ 230 cr (Incl. Tax) Dividend (%) 400% 400% 800% Outlay ₹ 174.6 cr ₹ 174.6 cr ₹ 349.2 cr Shares Acquired 46.5 lac Payout ratio (on PAT) 48% Total Outla

  26. Slide 26: Key Distribution Initiatives

    Key Distribution Initiatives Project SAMT Project KHOJ Chemist Outlet Expansion Beat Optimization • Optimised beats & MR time Sales Sales Sales freed-up & redeployed to growth of growth of growth of cover additional retail outlets 29% 30% 2.6x • Focus on continuous over PY over PY over PY improvemen

  27. Slide 27: Key ESG Initiatives: FY24

    Key ESG Initiatives: FY24 12% 17% reduction reduction 1,39,619 2,54,718 Energy 1,28,486 Water 2,21,477 Consumption 1,23,382 Consumption 2,11,586 (GJ) (KL) FY22 FY23 FY24 FY22 FY23 FY24 Renewable Energy Plastic Recycled CSR Initiatives 19% 5.7 of total energy consumption 10,485 MT lac beneficiaries F

  28. Slide 28: Thank you

    Thank you ~15% 24

Emami — Q4 FY2024 Earnings Presentation on 6ix